LINES DESIGN

Trademark usage description

pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gast Read More

Vienna Information

26 . 13 . 1

Stains, spots, blots, brush strokesTaches, coups de pinceau

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 21

Set of lines evoking speed or propulsionEnsemble de lignes évoquant la vitesse ou la propulsion

26 . 13 . 25

Other geometrical figures, indefinable designs -- Note: Including scratch marks.Autres figures géométriques, dessins indéfinissables -- Note: Y compris les marques de griffes.

2 . 9 . 25

Other parts of the human body -- Notes: (a) Including human or animal sperm. (b) Not including heads, which will be placed in the appropriate sections of divisions 2.1, 2.3, 2.5 or 2.7.Autres parties du corps humain -- Notes: Y compris le sperme humain ou animal. (b) Non compris les têtes qui seront rangées dans les sections appropriées des divisions 2.1, 2.3, 2.5 ou 2.7.

2 . 9 . 26

BrainsCerveaux

29 . 1 . 5

VioletViolet

29 . 1 . 3

GreenVert

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information

Class [005]
Pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gastrointestinal, musculoskeletal, nephrological, oncological, ophthalmic, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and dermatitis; Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations and substances for the prevention and treatment of genitourinary diseases and disorders, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations and substances for the prevention and treatment of gynecological diseases and disorders, namely amenorrhoea, dysmenorrheal and diseases and disorders relating to sexual reproduction and fertility; Pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, arthritis, obesity and hypothyroidism; Pharmaceutical preparations and substances for the prevention and treatment of pain; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses and bipolar disorders; Pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); Pharmaceutical preparations substances for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, urticaria and urinary incontinence; Pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; Human vaccine preparations; Inhaled pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders

Classification kind code

Mark Details

Serial Number

2274431

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 19^th Nov 2024	Search Recorded
Submitted for opposition 20 on 19^th Nov 2024	Examiner's First Report
Submitted for opposition 223 on 19^th Nov 2024	Total Provisional Refusal
Submitted for opposition 256 on 10^th Jun 2024	Notification of Possible Opposition Sent
Submitted for opposition 48 on 13^th Nov 2023	Agent Changed
Submitted for opposition 257 on 10^th Aug 2023	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 9^th Aug 2023	Formalized
Submitted for opposition 1 on 9^th Aug 2023	Created
Submitted for opposition 30 on 4^th Jul 2023	Filed
Submitted for opposition 228 on 4^th Jul 2023	International Registration